Angiogenesis

Angiogenesis is the physiological process through which new blood vessels are formed from pre-existing ones. This complex and tightly regulated mechanism plays a pivotal role in various physiological and pathological conditions. Essential for tissue growth, development, and repair, angiogenesis is also a hallmark of diseases such as cancer. Angiogenesis involves a sequence of events, including the activation of endothelial cells lining existing blood vessels, degradation of the extracellular matrix, migration and proliferation of endothelial cells, and the formation of new capillaries. Growth factors and signaling molecules, such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and angiopoietin, orchestrate this process. In physiological contexts, angiogenesis occurs during embryonic development, wound healing, and the female reproductive cycle. However, dysregulated angiogenesis is associated with diseases such as cancer, diabetic retinopathy, and rheumatoid arthritis. In cancer, for instance, tumors stimulate angiogenesis to ensure a blood supply for their growth and metastasis. Understanding the molecular mechanisms and signaling pathways involved in angiogenesis is crucial for developing therapeutic strategies. Anti-angiogenic therapies, which inhibit the formation of new blood vessels, are explored for cancer treatment, while pro-angiogenic approaches aim to promote blood vessel formation to enhance tissue regeneration. Angiogenesis research holds significant promise for advancing medical interventions in various fields, from oncology to regenerative medicine.